We are live on ! Find out more
ALPN

Alpine Immune Sciences Inc

Delisted

ALPN was delisted on the 17th of May, 2024.

22 hedge funds and large institutions have $69.2M invested in Alpine Immune Sciences Inc in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

195% more capital invested

Capital invested by funds: $23.5M → $69.2M (+$45.7M)

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

29% more funds holding

Funds holding: 1722 (+5)

Holders
22
Holders Change
+5
Holders Change %
+29.41%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
5
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$35.6M
FM
2
Frazier Management
Washington
$25M
Renaissance Technologies
3
Renaissance Technologies
New York
$2.18M +$396K +91,500 +69%
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.82M
TM
5
Tiger Management
New York
$1.34M
Two Sigma Investments
6
Two Sigma Investments
New York
$760K +$339K +78,299 New
BCA
7
Berman Capital Advisors
Georgia
$529K +$236K +54,524 New
HP
8
Hikari Power
Japan
$490K -$507K -117,143 -70%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$394K -$23.6K -5,443 -12%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$376K +$5.79K +1,338 +4%
BlackRock
11
BlackRock
New York
$291K +$27.5K +6,363 +27%
LRIA
12
Leonard Rickey Investment Advisors
Washington
$97K
PFO
13
Pathstone Family Office
New Jersey
$97K +$43.3K +10,010 New
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$81K +$13K +3,002 +56%
IC
15
Ikarian Capital
Texas
$46K +$20.5K +4,739 New
Morgan Stanley
16
Morgan Stanley
New York
$40K +$17.6K +4,068 +58,114%
UBS Group
17
UBS Group
Switzerland
$11K +$4.83K +1,116 New
TRCT
18
Tower Research Capital (TRC)
New York
$2K +$766 +177 New
SSB
19
Sandy Spring Bank
Maryland
$2K +$1.08K +250 New
BI
20
BVF Inc
California
-$3.28M -1,137,764 Closed
AWCI
21
Alpine Woods Capital Investors
New York
-$30K -10,580 Closed
Northern Trust
22
Northern Trust
Illinois
-$29K -10,188 Closed
Victory Capital Management
23
Victory Capital Management
Texas
-$8K -3,092 Closed
JP Morgan Chase
24
JP Morgan Chase
New York
+$13 +3 New
Bank of America
25
Bank of America
North Carolina
+$125 +29 New

ALPN Hedge Fund Activity: Q2 2020 in Review

22 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q2 2020, worth a combined $69.2M — up 195% from $23.5M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ALPN positions and 4 closed out — a net gain of 5 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $396K. The largest seller was BVF Inc, exiting entirely with an estimated $3.28M sold.

  • 22 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q2 2020, up from 17 in Q1 2020.
  • Funds reported $69.2M of Alpine Immune Sciences Inc stock for Q2 2020, up 195% quarter-over-quarter.
  • 9 funds opened new Alpine Immune Sciences Inc positions in Q2 2020 and 4 closed out, a net change of +5 holders.
  • The largest Alpine Immune Sciences Inc buyer in Q2 2020 was Renaissance Technologies, an estimated $396K added.
  • The largest Alpine Immune Sciences Inc seller in Q2 2020 was BVF Inc, an estimated $3.28M sold.

Based on aggregated 13F filings for Q2 2020.